ADAGE CAPITAL PARTNERS GP, L.L.C.

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1165408 Boston, MA

Position in CGEM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,333,980

-$8,216,754 QoQ

Shares Held

238,000

-76.9% QoQ

Ownership

0.370%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#42

of 183 holders

Holding Since

Mar 2021

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 125 Biotechnology names. CGEM ranks #94 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	10,349,328	$366,262,717
2	PRAX	Praxis Precision Medicines, Inc.	1,015,480	$339,972,549
3	VRTX	Vertex Pharmaceuticals Inc / Ma	393,964	$195,693,737
4	TNGX	Tango Therapeutics, Inc.	5,600,000	$175,056,000
5	BBIO	BridgeBio Pharma, Inc.	2,252,000	$167,728,960
6	SYRE	Spyre Therapeutics, Inc.	1,722,300	$152,905,794
7	TVTX	Travere Therapeutics, Inc.	2,569,356	$145,965,114
8	RPRX	Royalty Pharma plc	2,500,000	$140,175,000

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,333,980	238,000	-76.9%	Shares	Sole	2026-08-14
2024-12-31	$12,550,734	1,030,438	-24.0%	Shares	Sole	2025-02-14
2024-09-30	$22,697,364	1,355,876	-39.3%	Shares	Sole	2024-11-14
2024-06-30	$38,940,537	2,232,829	+135.0%	Shares	Sole	2024-08-14
2024-03-31	$16,188,000	950,000	-17.4%	Shares	Sole	2024-05-15
2023-09-30	$10,407,500	1,150,000	0.0%	Shares	Sole	2023-11-14
2023-06-30	$12,374,000	1,150,000	+1374.4%	Shares	Other	2023-08-14
2021-06-30	$2,008,500	78,000	-77.2%	Shares	Sole	2021-08-16
2021-03-31	$14,239,930	341,731	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.